Stay updated on Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a system-wide notice about potential data delays due to a lapse in government funding and updated operating status guidance, with references to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T06:22:28.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a glossary display and updated QC-related metadata to show 2025-10-20 Last Update Submitted that Met QC Criteria and Last Update Posted, along with No FEAR Act Data and Revision: v3.4.0. Removed older QC metadata (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) and the prior Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-28T04:20:06.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive changes to study content, layout, or links are evident.
    Difference
    0.0%
    Check dated 2026-01-14T03:22:36.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A consolidated Locations section was added and organized to list study sites in California, Connecticut, Texas, and Washington, with related per-location entries updated accordingly.
    Difference
    0.4%
    Check dated 2025-12-23T20:24:15.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Publications section wording now states that publications are automatically filled from PubMed, and the revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:25:36.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page no longer shows the government funding lapse notice regarding NIH operations. The study details and participation information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T19:16:22.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.